Tarlac's COVID-19 cases down by almost 400 in a week | Inquirer News

Tarlac’s COVID-19 cases down by almost 400 in a week

/ 10:35 AM January 29, 2022

60 more Tarlac residents contract COVID-19; death toll rises to 744

MABALACAT CITY, Pampanga – The active COVID-19 cases in Tarlac province dropped to 959 on Friday, from 1,342 a week ago, data from the provincial government showed.

On Friday, Tarlac registered 122 new cases, 274 recoveries and zero deaths.

ADVERTISEMENT

On Thursday, the province recorded 127 new cases, 207 recoveries and a single death.

FEATURED STORIES

A five-month-old boy from Tarlac City and a nine-month-old from Mayantoc town were among the new cases on Friday. Both had mild to moderate symptoms and were confined in medical facilities.

The capital city of Tarlac has the most active cases at 423, followed by Capas with 89 and Concepcion with 69.

Since the pandemic broke out in 2020, the province has recorded a total of 22,290 COVID-19 cases, of which 20,482 have recovered while 849 had died.

As of Friday, the provincial government said at least 893,404 residents have been fully vaccinated against the viral disease.

The number is 59.4 percent of Tarlac’s total population of 1,503,456, based on the 2020 national census.

Some 103,818 residents are still waiting for their second dose of the vaccine.

gsg
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: COVID-19, Tarlac

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.